Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseases.
Lescaudron L, Boyer C, Bonnamain V, Fink KD, Lévêque X, Rossignol J, Nerrière-Daguin V, Malouet AC, Lelan F, Dey ND, Michel-Monigadon D, Lu M, Neveu I, von Hörsten S, Naveilhan P, Dunbar GL. Lescaudron L, et al. Methods Mol Biol. 2012;879:147-64. doi: 10.1007/978-1-61779-815-3_10. Methods Mol Biol. 2012. PMID: 22610559
Local control of the host immune response performed with mesenchymal stem cells: perspectives for functional intracerebral xenotransplantation.
Lévêque X, Mathieux E, Nerrière-Daguin V, Thinard R, Kermarrec L, Durand T, Haudebourg T, Vanhove B, Lescaudron L, Neveu I, Naveilhan P. Lévêque X, et al. Among authors: lescaudron l. J Cell Mol Med. 2015 Jan;19(1):124-34. doi: 10.1111/jcmm.12414. Epub 2014 Oct 14. J Cell Mol Med. 2015. PMID: 25310920 Free PMC article.
New lines of GFP transgenic rats relevant for regenerative medicine and gene therapy.
Remy S, Tesson L, Usal C, Menoret S, Bonnamain V, Nerriere-Daguin V, Rossignol J, Boyer C, Nguyen TH, Naveilhan P, Lescaudron L, Anegon I. Remy S, et al. Among authors: lescaudron l. Transgenic Res. 2010 Oct;19(5):745-63. doi: 10.1007/s11248-009-9352-2. Epub 2010 Jan 22. Transgenic Res. 2010. PMID: 20094912
Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.
Fink KD, Crane AT, Lévêque X, Dues DJ, Huffman LD, Moore AC, Story DT, Dejonge RE, Antcliff A, Starski PA, Lu M, Lescaudron L, Rossignol J, Dunbar GL. Fink KD, et al. Among authors: lescaudron l. Stem Cells Transl Med. 2014 May;3(5):620-31. doi: 10.5966/sctm.2013-0151. Epub 2014 Mar 21. Stem Cells Transl Med. 2014. PMID: 24657963 Free PMC article.
Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number.
Rossignol J, Fink KD, Crane AT, Davis KK, Bombard MC, Clerc S, Bavar AM, Lowrance SA, Song C, Witte S, Lescaudron L, Dunbar GL. Rossignol J, et al. Among authors: lescaudron l. Stem Cell Res Ther. 2015 Feb 19;6(1):9. doi: 10.1186/scrt545. Stem Cell Res Ther. 2015. PMID: 25971780 Free PMC article.
47 results